全文获取类型
收费全文 | 5895篇 |
免费 | 463篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 211篇 |
妇产科学 | 102篇 |
基础医学 | 842篇 |
口腔科学 | 64篇 |
临床医学 | 667篇 |
内科学 | 1370篇 |
皮肤病学 | 92篇 |
神经病学 | 562篇 |
特种医学 | 149篇 |
外科学 | 697篇 |
综合类 | 55篇 |
一般理论 | 1篇 |
预防医学 | 620篇 |
眼科学 | 88篇 |
药学 | 487篇 |
中国医学 | 18篇 |
肿瘤学 | 338篇 |
出版年
2024年 | 6篇 |
2023年 | 85篇 |
2022年 | 99篇 |
2021年 | 254篇 |
2020年 | 160篇 |
2019年 | 220篇 |
2018年 | 222篇 |
2017年 | 161篇 |
2016年 | 196篇 |
2015年 | 206篇 |
2014年 | 244篇 |
2013年 | 317篇 |
2012年 | 461篇 |
2011年 | 502篇 |
2010年 | 256篇 |
2009年 | 226篇 |
2008年 | 404篇 |
2007年 | 360篇 |
2006年 | 404篇 |
2005年 | 351篇 |
2004年 | 308篇 |
2003年 | 282篇 |
2002年 | 200篇 |
2001年 | 43篇 |
2000年 | 33篇 |
1999年 | 50篇 |
1998年 | 44篇 |
1997年 | 35篇 |
1996年 | 23篇 |
1995年 | 39篇 |
1994年 | 17篇 |
1993年 | 12篇 |
1992年 | 24篇 |
1991年 | 15篇 |
1990年 | 14篇 |
1989年 | 18篇 |
1988年 | 6篇 |
1987年 | 9篇 |
1986年 | 4篇 |
1985年 | 9篇 |
1984年 | 8篇 |
1983年 | 12篇 |
1982年 | 8篇 |
1979年 | 4篇 |
1976年 | 3篇 |
1972年 | 3篇 |
1970年 | 4篇 |
1968年 | 2篇 |
1967年 | 3篇 |
1966年 | 2篇 |
排序方式: 共有6387条查询结果,搜索用时 15 毫秒
961.
962.
In recent years, many analogs of narcotics have been widely distributed as easily available psychotropic substances and have become a serious problem in Japan. To counter the spread of these non-controlled substances, the Pharmaceutical Affairs Law in Japan was amended in 2006 to establish a new category, "designated substances", to more strictly control these psychotropic substances. Fifty-one substances have been listed in this category as of December 2010. However, many new analogs have appeared, one after the other. Although the distribution of tryptamine-type designer drugs has decreased since the amendment of the law, the distribution of cathinone derivatives, as well as of phenetylamine-type and piperazine-type designer drugs, has increased. Moreover, non-controlled psychotropic plants have become popular in place of chemical psychotropic substances, which are now subject to stricter controls. Additionally, since 2008, new herbal products containing synthetic cannabinoids (for example, a brand named "Spice") have appeared. Sixteen synthetic cannabinoids, classified into four groups, have been detected in products purchased up to December 2010 via Japanese-based websites. The distribution of products containing the psychoactive substances described above (so-called "legal highs" in European countries) is a worldwide problem. In this review, we survey current trends in the abuse of psychotropic substances and plants in Japan, focusing especially on synthetic cannabinoids, cathinone derivatives and psychotropic plants. 相似文献
963.
964.
Constantino Fernández Rivera María Calvo Rodríguez Andrés López Muñíz Tamara Ferreiro Hermida Rocío Seijo Bestilleiro Concepción Andón Saavedra Andrea Galego García Angel Alonso Hernández 《Nefrología : publicación oficial de la Sociedad Espa?ola Nefrologia》2019,39(6):612-622
BackgroundABO-incompatible living-donor kidney transplantation was regarded as an absolute contraindication. However, it has been carried out for years with good outcomes.ObjectiveOur aim was to show the results obtained with this technique in our hospital.MethodsForty-eight patients with a mean age of 50.9 ± 10.9 years were included. Follow-up was 44.6 ± 30.9 months. Conditioning: rituximab 375 mg/m2, tacrolimus, mycophenolate mofetil or mycophenolate sodium, prednisone, plasmapheresis/immunoadsorption and intravenous immunoglobulin. Accepted IgG and IgM titres for transplantation: < 1:8.ResultsPre-process IgG titre 1:124 ± 1:140, IgM titre 1:77 ± 1:55. After 6 ± 3 sessions, IgG decreased to < 1:8 in 47 patients and to < 1:16 in one. IgM was < 1:8 in all cases. Twenty-four patients (50%) had haematoma, 7 re-intervention (14.6%), 29 (60%) required transfusion. At 5 years, acute rejection had occurred in 5 cases (8.7%), CMV infection in 9 (19.7%), BK viraemia in 5 (12.4%), post-transplant diabetes in 10 (23.4%) and lymphocele in 3 (6.4%). Patient survival was 97.1% at 5 years and graft survival 95.7% at one year and 93% at 5 years. Causes of graft loss: thrombosis (n = 1); mixed rejection (n = 1); and death (n = 2). Serum creatinine levels were 1.4 ± 0.4 mg/dl at one and 3 years and 1.3 ± 0.3 mg/dl at 5 years. Proteinuria was 0.2 ± 0.2 g/24 h at one, 3 and 5 years.ConclusionsABO-incompatible living-donor kidney transplantation after conditioning with rituximab, plasmapheresis/immunoadsorption and immunoglobulins is a valid option offering excellent outcomes. There is a low incidence of acute rejection and no increase in infectious complications. An increased tendency for postoperative bleeding was found. 相似文献
965.
966.
Sofie G. Højfeldt Benjamin O. Wolthers Morten Tulstrup Jonas Abrahamsson Ramneek Gupta Arja Harila-Saari Mats Heyman Louise T. Henriksen Òlafur G. Jónsson Päivi M. Lähteenmäki Bendik Lund Kaie Pruunsild Goda Vaitkeviciene Kjeld Schmiegelow Birgitte K. Albertsen the Nordic Society of Paediatric Haematology Oncology group 《British journal of haematology》2019,184(3):405-417
Asparaginase is essential in childhood acute lymphoblastic leukaemia (ALL) treatment, however hypersensitivity reactions to pegylated asparaginase (PEG-asparaginase) hampers anti-neoplastic efficacy. Patients with PEG-asparaginase hypersensitivity have been shown to possess zero asparaginase enzyme activity. Using this measurement to define the phenotype, we investigated genetic predisposition to PEG-asparaginase hypersensitivity in a genome-wide association study (GWAS). From July 2008 to March 2016, 1494 children were treated on the Nordic Society of Paediatric Haematology and Oncology ALL2008 protocol. Cases were defined by clinical hypersensitivity and no enzyme activity, controls had enzyme activity ≥ 100 iu/l and no hypersensitivity symptoms. PEG-asparaginase hypersensitivity was reported in 13·8% (206/1494) of patients. Fifty-nine cases and 772 controls fulfilled GWAS inclusion criteria. The CNOT3 variant rs73062673 on 19q13.42, was associated with PEG-asparaginase allergy (P = 4·68 × 10−8). We further identified two signals on chromosome 6 in relation to HLA-DQA1 (P = 9·37 × 10−6) and TAP2 (P = 1·59 × 10−5). This study associated variants in CNOT3 and in the human leucocyte antigen (HLA) region with PEG-asparaginase hypersensitivity, suggesting that not only genetic variations in the HLA region, but also regulation of these genes are of importance in the biology of this toxicity. Furthermore, our study emphasizes the importance of using asparaginase enzyme activity measurements to identify PEG-asparaginase hypersensitivity. 相似文献
967.
968.
969.
Erin L. P. Bradley Emma L. Frazier Tamara Carree Donna Hubbard McCree Madeline Y. Sutton 《AIDS care》2019,31(8):932-941
Black women are disproportionately affected by HIV, accounting for 61% of women diagnosed in 2016. Black women with HIV are less likely to be adherent to antiretroviral therapy (ART) and virally suppressed compared to women of other racial/ethnic groups. We analyzed 2013–2014 data from 1703 black women patients in the Centers for Disease Control and Prevention’s Medical Monitoring Project to examine whether select psychological and social determinants of health (SDH) factors were associated with ART adherence and viral suppression. We calculated weighted estimates and used multivariable logistic regression with adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) to examine correlates of ART adherence and viral suppression. Women who had not been incarcerated in the past 12 months (aPR?=?1.24; CI: 1.04–1.48) and had not experienced discrimination in a health care setting since their HIV diagnosis (aPR?=?1.06; 1.00–1.11) were slightly more likely to be adherent to ART. Women who lived above the federal poverty level were more likely to be virally suppressed during the past 12 months (aPR?=?1.09; CI: 1.01–1.18). More research is warranted to identify the best strategies to create health care settings that encourage black women’s HIV care engagement, and to address other key SDH and/or psychological factors. 相似文献
970.
Nation TR Buraundi S Balic A Farmer PJ Newgreen D Southwell BR Hutson JM 《Journal of pediatric surgery》2011,46(12):2358-2362